Tregs, as a prominent mechanism for the controlling equilibrium of the immune system and the immune tolerance of the body, play an essential role in regulating tumor immunity, and they can hinder the activation and differentiation of CD4+ helper T cells and CD8+ cytotoxic T cells to promote reactivity against autologous and tumor-expressed antigens [22,23,24]. Here, CD4 is linked to neoplasm.